Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | AGXT | P21549 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30570479 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL18462883 | 0.91 | ALDH1A1 (0.44) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL17236452 | 0.81 | ALDH1A1 (0.44) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL2407958 | 0.79 | ORAI1 (0.44) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL39406 | 0.79 | CES2 (0.43) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL29395656 | 0.79 | CES2 (0.43) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL31047615 | 0.78 | CA3 (0.46) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL2065706 | 0.78 | CA3 (0.46) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL26576590 | 0.75 | CES2 (0.40) | ALDH1A1CES2CES1CA3CA6 | |
| SCHEMBL19726536 | 0.74 | ACHE (0.38) | ALDH1A1CA3CA6CA5ACA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116693732-A | Acrylic ester polymerization reaction method based on synergistic regulation and control of hydrogen bond and Lewis acid and under synergistic regulation and control of no hydrogen bond and Lewis acid | 青岛大学 | 2023-09-05 | — | — | CN | disclosed |
| WO-2017016653-A1 | NOVEL COMPOUNDS EXHIBITING PHOTOPHYSICAL PROPERTIES UPON FORMATION OF LEWIS ACID-BASE ADDUCTS USING NON-CHELATING BORANES, METHOD FOR PRODUCING THE SAME AND DEVICES INCLUDING THE SAME | Universität Heidelberg (DE) | 2017-02-02 | — | — | WO | disclosed |
| US-6864334-B2 | Multi-dentate late transition metal catalyst complexes and polymerization methods using those complexes | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2005-03-08 | — | — | US | disclosed |
| US-20050004334-A1 | MULTI-DENTATE LATE TRANSITION METAL CATALYST COMPLEXES AND POLYMERIZATION METHODS USING THOSE COMPLEXES | BOFFA LISA SAUNDERS (US) | 2005-01-06 | — | — | US | disclosed |
| US-20040254067-A1 | Multi-dentate late transition metal catalyst complexes and polymerization methods using those complexes | BOFFA LISA SAUNDERS (US) | 2004-12-16 | — | — | US | disclosed |
| US-6809058-B2 | CU, AG AND AU COMPLEXES HAVING A MULTIDENTATE NITROGEN-CONTAINING LIGAND, SUCH AS 2,2':6',2'-TERPYRIDINE, (2,6-BIS(1-PHENYLIMINO) ETHYL)PYRIDINE, 1,4,7-TRIAZACYCLONONANE, OR THEIR SUBSTITUTED DERIVATIVES. | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2004-10-26 | — | — | US | disclosed |
| US-20030069128-A1 | Multi-dentate late transition metal catalyst complexes and polymerization methods using those complexes | EXXONMOBIL RESEARCH & ENGINEERING COMPANY | 2003-04-10 | — | — | US | disclosed |
| WO-2003020778-A1 | MULTI-DENTATE LATE TRANSITION METAL CATALYST COMPLEXES AND POLYMERIZATION METHODS USING THOSE COMPLEXES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2003-03-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004334-A1 | MULTI-DENTATE LATE TRANSITION METAL CATALYST COMPLEXES AND POLYMERIZATION METHODS USING THOSE COMPLEXES | NOX3, CA3, KCNN4 | ALDH1A1 2611/4885CES2 3328/4885CES1 4355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.